Early research (Phase 1)Study completedNCT02454699
What this trial is testing
Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24